The patient-reported attending a follow-up appointment with a primary care physician, who advised the patient to follow-up with the implanting clinician because the wound seemed to be infected and one of the leads appeared to be eroding.The patient reached out to the clinical representative immediately.The clinical representative recommended the patient call the implanting clinician's office and schedule a follow-up.On (b)(6) 2020, the patient was seen by one of the associates of the implanting clinician, who determined that the tail of the lead was protruding out of the patient's incision and recommended the leads be removed and re-implanted.The patient was instructed to follow-up with the implanting clinician on (b)(6) 2020, to discuss further options.On (b)(6) 2020, the implanting clinician told the patient that the plan is to explant and implant new leads immediately after bwc grants the approval.On (b)(6) 2021, the clinical representative was made aware by the patient that during a follow-up appointment on (b)(6) 2020, that the infection was found to be getting worse, and the implanting clinician explanted both leads and prescribed antibiotics (dosage, name, frequency unknown) to treat the infection.The implanting clinician plans to implant new stimulators once the infection has cleared.The procedure was reported to have been performed per the product ifu.Stimwave has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The cause of the infection is no problem found.
|